Redcare appoints Peter Schmid von Linstow as CEO: stock pre-market at EUR 73.43
Published on 10/16/2026 at 07:43 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSOutlook for the session
- Redcare Pharmacy appointed Peter Schmid von Linstow as CEO effective October 14, 2026.
- Redcare Pharmacy stock trades pre-market at EUR 73.43 at 7:42 a.m. CEST at Lang & Schwarz on October 16, 2026.
- The next round-number level is EUR 75.00, which is 2.14 percent above the pre-market price.
- Redcare Pharmacy is scheduled to publish its Q3 2026 interim statement on October 29, 2026.
On October 14, 2026, Redcare Pharmacy appointed Peter Schmid von Linstow as a member of the Managing Board and chief executive officer following consultation with its Extraordinary General Meeting. At 7:42 a.m. CEST on October 16, 2026, Redcare Pharmacy stock trades pre-market at EUR 73.43 at Lang & Schwarz. The appointment and effective date were reported by EQS News.
Pre-market trading
The Lang & Schwarz bid is EUR 73.20 and the ask is EUR 73.65. A round-number level at EUR 75.00 is 2.14 percent above the pre-market price. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Redcare Pharmacy stock.
What matters today
Redcare Pharmacy’s next scheduled company date is its Q3 2026 interim statement on October 29, 2026, according to the company’s investor-relations information carried with the announcement. The next round-number level is EUR 75.00, representing a calculated distance of 2.14 percent from EUR 73.43. The CEO appointment took effect on October 14, 2026, and Schmid von Linstow said his focus would include customer relationships, technology investment and profitable growth, according to EQS News.
Market context: Market report DAX.
